Volume 26, Number 2—February 2020
Ocular Spiroplasma ixodetis in Newborns, France
Cataract and uveitis are rare in newborns but potentially blinding. Three newborns with cataract and severe anterior uveitis underwent cataract surgery. Spiroplasma ixodetis was detected in lens aspirates using bacterial 16S-rRNA PCR and transmission electron microscopy. These findings, which suggest maternal–fetal infection, are consistent with previous experimental Spiroplasma-induced cataract and uveitis.
Spiroplasma is a genus of Mollicutes, a class of bacteria without cell wall. Spiroplasma are intracellular organisms with helical morphology and a small genome (0.78–2.2 Mb) comprising 38 species isolated from insects, crustaceans, and plants (1,2). Ticks, from which Spiroplasma ixodetis has been isolated, are abundant sources of Spiroplasma (3).
Spiroplasma develop a commensal, pathogenic, or mutualist pathogen–host relationship. The first isolated species (S. citri) was described in 1973 (4,5). Two Spiroplasma infections have been reported in humans: an intraocular infection in a newborn with Group VI Spiroplasma, now known as S. ixodetis (6), and a systemic infection in an immunocompromised adult with S. turonicum (7). These reports suggest that tetracyclines and macrolides are effective against Spiroplasma (6,7). We describe 3 newborns in France who had cataract and intraocular inflammation and in whom S. ixodetis was detected in ocular samples (Table).
In January 2014, case-patient 1, a 26-day-old girl with unremarkable medical history, was referred for bilateral leukocoria observed by her parents at 20 days of age, suggestive of retinoblastoma. She was born after normal full-term pregnancy without delivery complications (birthweight 2,820 g; Apgar score 10). She had bilateral anterior uveitis, large keratic precipitates, iris nodules, posterior synechiae, cyclitic membrane, and cataract (Figure 1, panels A, B). Fundus visualization and ocular ultrasonography ruled out retinoblastoma. Physical examination results were unremarkable. Blood cell count showed elevated monocytes (1.5 × 109/L [reference range 0.2–1.0 × 109/L]); serologic results for Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex viruses 1 and 2, HIV-1 and -2, and Mycoplasma were negative. Aqueous humor cytologic examination did not reveal malignant cells but identified macrophages, suggesting intraocular infection, as observed in Tropheryma whipplei–related uveitis (8). Treatment with topical dexamethasone (8 drops/d with progressive tapering), topical atropine (0.3%, 2 drops/d), and oral josamycin (125 mg 2×/d) was initiated. Anterior chamber inflammation decreased dramatically, and cataract surgery with intraocular lens implantation was performed sequentially in both eyes 4 weeks later. We conducted microbiological investigations of lens and anterior vitreous aspirates from the right eye, including bacteriologic and mycologic cultures, and 16S-rRNA-based PCR for bacterial identification (Appendix). Cultures remained negative, but bacterial PCR identified a complete sequence of the rrs gene, showing 98.7% similarity to the type strains of S. ixodetis (Figure 2). Uveitis did not recur over the next 4 years.
In January 2018, bilateral leukocoria caused by bilateral congenital cataract was detected in an otherwise healthy boy, case-patient 2, on day 3 after full-term birth (birthweight 2,900 g; Apgar score 10). Pregnancy was unremarkable, without maternal seroconversion for toxoplasmosis, rubella, herpes simplex viruses 1 and 2, or cytomegalovirus. Six weeks after birth, ophthalmologic examination under anesthesia revealed a total cataract in each eye with large keratic precipitates, posterior synechiae, and immature dilated iris vessels (Figure 1, panels C, D). Fundus was inaccessible in both eyes. The right eye was slightly microphthalmic. Because of the rarity of uveitis with keratic precipitates and cataract in newborns and the similarity to case-patient 1, the child underwent bilateral cataract extraction without lens implantation, and lens material was sent for bacteriologic investigations. The 16S-rRNA–based PCR of the rrs gene identified in both eyes was 98.6% similar to S. ixodetis. Mild, self-resolving bilateral intravitreal hemorrhage developed after cataract surgery. Anterior segment inflammation resolved under topical dexamethasone (4 drops/d with progressive tapering over 3 months) and atropine (0.3%, 1 drop/d for 1 month) and did not recur over the next 18 months.
In January 2019, case-patient 3, a 1-month-old boy, was referred for left eye leukocoria, first observed 1 week after birth. Pregnancy was uneventful, and delivery was normal at 36 weeks’ gestation (birthweight 2,800 g; Apgar score 10). Left eye examination revealed multiple large keratic white deposits, total cataract, posterior synechiae, and immature dilated iris vessels (Figure 1, panel E). Results of a right eye examination were unremarkable. He underwent cataract extraction with synechialysis, without intraocular lens implantation. 16S rRNA–based PCR of the bacterial rrs gene performed on crystalline lens aspirates identified S. ixodetis with 98.7% similarity. Fresh crystalline lens samples analyzed by electron transmission microscopy revealed microorganisms with spiral-like projections matching the morphology of bacteria from the Spiroplasma genus (Figure 1, panel F). Postoperative mild intravitreal hemorrhage developed but self-resolved over 4 weeks. He was treated postoperatively with oral josamycin (125 mg 2×/d for 10 days), topical atropine (0.3% 2×/d for 1 month), and topical drops combining neomycin, polymixin B, and dexamethasone (4×/d with progressive tapering over 1 month). Intraocular inflammation did not recur over the next 6 months.
We conducted all PCRs in Spiroplasma DNA–free facilities. Internal negative controls were introduced during DNA manipulation/amplification (Appendix). No control was positive after 16S-rRNA PCR amplification, confirming that the detection of Spiroplasma sequences did not result from contamination.
To confirm that S. ixodetis is absent in intraocular media of newborns with noninflammatory cataracts, we collected crystalline lens samples from 5 newborns with congenital cataracts who underwent surgery before 6 months of age (Table). 16S rRNA–based PCR did not identify any bacterial signature in these samples. The Internal Review Board of the French Society of Ophthalmology approved this study.
Until recently, Spiroplasma spp. were considered nonpathogenic in humans. Our observations confirm the reports by Lorenz et al. of an intraocular Spiroplasma spp. infection (6), and by Aquilino et al. of a systemic infection (7). Moreover, the congenital presentation of case-patients 1–3 suggests maternal–fetal transmission during pregnancy or delivery, despite the absence of maternal symptoms. Our findings are consistent with those of Lorenz et al., who described a premature baby born at 27 weeks’ gestation who, at 4 months of age, had unilateral uveitis with corneal precipitates, posterior synechiae, and cataract. After cataract surgery, bacterial 16S-rRNA PCR of vitreous and lens aspirates identified Spiroplasma spp. Group VI (6), now referred to as S. ixodetis (9). Electron microscopy visualized filamentous and helical microorganisms compatible with Spiroplasma.
Another clade of Spiroplasma, S. mirum, phylogenetically close to S. ixodetis (Figure 2), initially named suckling mouse cataract agent (9,10), induces rapid cataract formation after intracerebral injection in newborn mice (11), rats (12), and rabbits (13), with variable intraocular inflammation. In these models, adult animals do not develop ocular pathology, suggesting a vulnerability of the immature eye to Spiroplasma infection. Moreover, a high rate of microphthalmia developed in these animals, as in case-patient 2, suggesting that Spiroplasma infection might interfere with ocular development.
Our observations suggest that intrauterine or early postnatal contamination with Spiroplasma spp. might lead to unilateral or bilateral cataract and anterior uveitis in newborns. A similar causative S. ixodetis subtype was identified in all 3 infants, without technical contamination. Two of 3 case-patients lived in a rural area adjacent to a forest.
The frequency of this intraocular infection in newborns may be underestimated. Spiroplasma are fastidious organisms detectable using PCR techniques not routinely performed on intraocular samples. Because affected infants are at high risk for visual impairment or blindness, pediatricians, ophthalmologists, and microbiologists should be aware of possible S. ixodetis ocular infections and collect clinical, bacteriologic, and epidemiologic data on this emerging pathogen. The mechanisms and timing of probable maternal–fetal transmission require further investigations. On the basis of these observations, we recommend systematic bacterial 16S-rRNA PCR analysis on intraocular fluids and lens material from neonates with cataract and uveitis.
Dr. Matet is an ophthalmologist and ocular oncology specialist at Institut Curie and Paris Descartes University. His primary research interests include pediatric and adult ocular tumors, radiation therapy, ocular inflammation and infection, and retinal imaging.
- Gasparich GE. Spiroplasmas: evolution, adaptation and diversity. Front Biosci. 2002;7:d619–40.PubMedGoogle Scholar
- Regassa LB, Gasparich GE. Spiroplasmas: evolutionary relationships and biodiversity. Front Biosci. 2006;11:2983–3002. DOIPubMedGoogle Scholar
- Cisak E, Wójcik-Fatla A, Zając V, Sawczyn A, Sroka J, Dutkiewicz J. Spiroplasma - an emerging arthropod-borne pathogen? Ann Agric Environ Med. 2015;22:589–93. DOIPubMedGoogle Scholar
- Tully JG, Whitcomb RF, Bove JM, Saglio P. Plant mycoplasmas: serological relation between agents associated with citrus stubborn and corn stunt diseases. Science. 1973;182:827–9. DOIPubMedGoogle Scholar
- Whitcomb RF, Tully JG, Bové JM, Saglio P. Spiroplasmas and acholeplasmas: multiplication in insects. Science. 1973;182:1251–3. DOIPubMedGoogle Scholar
- Lorenz B, Schroeder J, Reischl U. First evidence of an endogenous Spiroplasma sp. infection in humans manifesting as unilateral cataract associated with anterior uveitis in a premature baby. Graefes Arch Clin Exp Ophthalmol. 2002;240:348–53. DOIPubMedGoogle Scholar
- Aquilino A, Masiá M, López P, Galiana AJ, Tovar J, Andrés M, et al. First human systemic infection caused by Spiroplasma. J Clin Microbiol. 2015;53:719–21. DOIPubMedGoogle Scholar
- Touitou V, Fenollar F, Cassoux N, Merle-Beral H, LeHoang P, Amoura Z, et al. Ocular Whipple’s disease: therapeutic strategy and long-term follow-up. Ophthalmology. 2012;119:1465–9. DOIPubMedGoogle Scholar
- Gasparich GE, Whitcomb RF, Dodge D, French FE, Glass J, Williamson DL. The genus Spiroplasma and its non-helical descendants: phylogenetic classification, correlation with phenotype and roots of the Mycoplasma mycoides clade. Int J Syst Evol Microbiol. 2004;54:893–918. DOIPubMedGoogle Scholar
- Tully JG, Whitcomb RF, Williamson DL, Clark HF. Suckling mouse cataract agent is a helical wall-free prokaryote (spiroplasma) pathogenic for vertebrates. Nature. 1976;259:117–20. DOIPubMedGoogle Scholar
- Olmsted E, Prasad S, Sheffer J, Clark HF, Karzon DT. Ocular lesions induced in C57 mice by the suckling mouse cataract agent (SMCA). Invest Ophthalmol. 1966;5:413–20.PubMedGoogle Scholar
- Friedlaender RP, Barile MF, Kuwabara T, Clark HF. Ocular pathology induced by the suckling mouse cataract agent. Invest Ophthalmol. 1976;15:640–7.PubMedGoogle Scholar
- Kirchhoff H, Heitmann J, Trautwein G. Pathogenicity of Spiroplasma sp. strain SMCA in rabbits: clinical, microbiological, and histological aspects. Infect Immun. 1981;33:292–6.PubMedGoogle Scholar
TableCite This Article
Original Publication Date: December 03, 2019
Table of Contents – Volume 26, Number 2—February 2020
|EID Search Options|
|Advanced Article Search – Search articles by author and/or keyword.|
|Articles by Country Search – Search articles by the topic country.|
|Article Type Search – Search articles by article type and issue.|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Alexandre Matet, Institut Curie, Service d’Ophtalmologie, 26 Rue d’Ulm, F-75248 Paris CEDEX 5, France